Palisade Bio (PALI) Net Cash Flow (2010 - 2026)
Palisade Bio (PALI) reported Net Cash Flow of -$757000.0 for Q1 2026, up 70.78% year-over-year from -$443251.3 in Q1 2025, and down 100.59% on a QoQ basis from $128.2 million in Q4 2025.
Palisade Bio (PALI) has 17 years of Net Cash Flow data on file, last reported at -$757000.0 in Q1 2026.
- Quarterly Net Cash Flow rose 70.78% year-over-year to -$757000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $125.4 million (up 3200.02% YoY) and the FY2025 annual result came in at $123.6 million, up 4833.55% from the prior year.
- Net Cash Flow eased to -$757000.0 in Q1 2026 per PALI's latest filing, from $128.2 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $128.2 million in Q4 2025 and bottomed at -$3.9 million in Q1 2022.
- The 5-year median for Net Cash Flow is -$1.1 million (2023), against an average of $7.2 million.
- The widest annual swing landed in 2022, when Net Cash Flow plunged 3829.59%; it then jumped 7097.47% in 2025.
- Tracing PALI's Net Cash Flow over 5 years: stood at -$1.6 million in 2022, then plunged by 79.78% to -$2.9 million in 2023, then surged by 161.84% to $1.8 million in 2024, then jumped by 7097.47% to $128.2 million in 2025, then slumped by 100.59% to -$757000.0 in 2026.
- Per Business Quant, the three latest PALI Net Cash Flow figures stand at -$757000.0 (Q1 2026), $128.2 million (Q4 2025), and -$190000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 625.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 457.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -152.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 60.68 Mn |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - | -757,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -757,000.00 |
| Mar 31, 2026 | -757,000.00 |
| Dec 31, 2025 | 128.19 Mn |
| Dec 31, 2025 | 128.19 Mn |
| Sep 30, 2025 | -190,000.00 |
| Sep 30, 2025 | -190,000.00 |
| Jun 30, 2025 | -1.81 Mn |
| Jun 30, 2025 | -1.81 Mn |
| Mar 31, 2025 | -2.59 Mn |
| Mar 31, 2025 | -2.59 Mn |
| Dec 31, 2024 | 1.78 Mn |
| Dec 31, 2024 | 1.78 Mn |
| Sep 30, 2024 | -3.31 Mn |
| Sep 30, 2024 | -3.31 Mn |
| Jun 30, 2024 | 77,000.00 |
| Jun 30, 2024 | 77,000.00 |
| Mar 31, 2024 | -1.16 Mn |
| Mar 31, 2024 | -1.16 Mn |
| Dec 31, 2023 | -2.88 Mn |
| Dec 31, 2023 | -2.88 Mn |
| Sep 30, 2023 | -1.09 Mn |
| Sep 30, 2023 | -1.09 Mn |
| Jun 30, 2023 | 3.11 Mn |
| Jun 30, 2023 | 3.11 Mn |
| Mar 31, 2023 | 914,000.00 |
| Mar 31, 2023 | 914,000.00 |
| Dec 31, 2022 | -1.60 Mn |
| Dec 31, 2022 | -1.60 Mn |
| Sep 30, 2022 | 9.01 Mn |
| Sep 30, 2022 | 9.01 Mn |
| Jun 30, 2022 | -1.66 Mn |
| Jun 30, 2022 | -1.66 Mn |
| Mar 31, 2022 | -3.85 Mn |
| Mar 31, 2022 | -3.85 Mn |
| Dec 31, 2021 | -3.61 Mn |
| Dec 31, 2021 | -3.61 Mn |
| Sep 30, 2021 | 1.45 Mn |
| Sep 30, 2021 | 1.45 Mn |
| Jun 30, 2021 | 11.74 Mn |
| Jun 30, 2021 | 11.74 Mn |
| Mar 31, 2021 | -98,000.00 |
| Mar 31, 2021 | -98,000.00 |
| Dec 31, 2020 | -38,000.00 |
| Dec 31, 2020 | -38,000.00 |
| Sep 30, 2020 | -768,000.00 |
| Sep 30, 2020 | -768,000.00 |
| Jun 30, 2020 | -6.99 Mn |
| Jun 30, 2020 | -6.99 Mn |
| Mar 31, 2020 | 4.92 Mn |
| Mar 31, 2020 | 4.92 Mn |
| Dec 31, 2019 | -2.19 Mn |
| Dec 31, 2019 | -2.19 Mn |
| Sep 30, 2019 | 5.02 Mn |
| Sep 30, 2019 | 5.02 Mn |
| Jun 30, 2019 | -1.72 Mn |
| Jun 30, 2019 | -1.72 Mn |
| Mar 31, 2019 | -1.78 Mn |
| Mar 31, 2019 | -1.78 Mn |
| Dec 31, 2018 | 52,728.00 |
| Dec 31, 2018 | 52,728.00 |
| Sep 30, 2018 | -1.35 Mn |
| Sep 30, 2018 | -1.35 Mn |
| Jun 30, 2018 | -2.63 Mn |
| Jun 30, 2018 | -2.63 Mn |
| Mar 31, 2018 | 3.05 Mn |
| Mar 31, 2018 | 3.05 Mn |
| Dec 31, 2017 | -2.39 Mn |
| Dec 31, 2017 | -2.39 Mn |
| Sep 30, 2017 | 2.62 Mn |
| Sep 30, 2017 | 2.62 Mn |
| Jun 30, 2017 | -5.14 Mn |
| Jun 30, 2017 | -5.14 Mn |
| Mar 31, 2017 | -3.51 Mn |
| Mar 31, 2017 | -3.51 Mn |
| Dec 31, 2016 | 9.52 Mn |
| Dec 31, 2016 | 9.52 Mn |
| Sep 30, 2016 | -5.45 Mn |
| Sep 30, 2016 | -5.45 Mn |
| Jun 30, 2016 | 3.51 Mn |
| Jun 30, 2016 | 3.51 Mn |
| Mar 31, 2016 | 2.90 Mn |
| Mar 31, 2016 | 2.90 Mn |
| Dec 31, 2015 | -8.41 Mn |
| Dec 31, 2015 | -8.41 Mn |
| Sep 30, 2015 | 4.48 Mn |
| Sep 30, 2015 | 4.48 Mn |
| Jun 30, 2015 | -4.94 Mn |
| Jun 30, 2015 | -4.94 Mn |
| Mar 31, 2015 | 1.07 Mn |
| Mar 31, 2015 | 1.07 Mn |
| Dec 31, 2014 | 573,830.00 |
| Dec 31, 2014 | 573,830.00 |
| Sep 30, 2014 | -3.29 Mn |
| Sep 30, 2014 | -3.29 Mn |
| Jun 30, 2014 | -3.11 Mn |
| Jun 30, 2014 | -3.11 Mn |
| Mar 31, 2014 | 1.50 Mn |
| Mar 31, 2014 | 1.50 Mn |
| Dec 31, 2013 | 443,482.00 |
| Dec 31, 2013 | 443,482.00 |
| Sep 30, 2013 | 5.23 Mn |
| Sep 30, 2013 | 5.23 Mn |
| Jun 30, 2013 | -1.49 Mn |
| Jun 30, 2013 | -1.49 Mn |
| Mar 31, 2013 | 5.22 Mn |
| Mar 31, 2013 | 5.22 Mn |
| Dec 31, 2012 | -2.43 Mn |
| Dec 31, 2012 | -2.43 Mn |
| Sep 30, 2012 | 7.33 Mn |
| Sep 30, 2012 | 7.33 Mn |
| Jun 30, 2012 | -2.60 Mn |
| Jun 30, 2012 | -2.60 Mn |
| Mar 31, 2012 | 2.79 Mn |
| Mar 31, 2012 | 2.79 Mn |
| Dec 31, 2011 | -1.84 Mn |
| Dec 31, 2011 | -1.84 Mn |
| Sep 30, 2011 | -1.95 Mn |
| Sep 30, 2011 | -1.95 Mn |
| Jun 30, 2011 | -2.40 Mn |
| Jun 30, 2011 | -2.40 Mn |
| Mar 31, 2011 | -714,809.00 |
| Mar 31, 2011 | -714,809.00 |
| Dec 31, 2010 | -2.33 Mn |
| Dec 31, 2010 | -2.33 Mn |
| Sep 30, 2010 | -2.44 Mn |
| Sep 30, 2010 | -2.44 Mn |